Liuzhou Liangmianzhen Co., Ltd. (SHA:600249)
4.770
-0.020 (-0.42%)
Oct 29, 2026, 3:00 PM CST
Liuzhou Liangmianzhen Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 959.44 | 1,063 | 1,053 | 995.14 | 669.19 | 717.53 |
Revenue Growth | -10.92% | 0.90% | 5.82% | 48.71% | -6.74% | 4.68% |
Gross Profit Gross Profit Growth | 148.32 | 172.78 | 171.37 | 160.8 | 104.94 | 143.07 |
Operating Income Operating Income Growth | -70.1 | -43.8 | -49 | -38.11 | -59.48 | -25.56 |
Net Income Net Income Growth | -45.55 | 9.85 | 81.1 | 22.81 | -38.59 | 8.66 |
Earnings Per Share EPS Growth | -0.08 | 0.02 | 0.15 | 0.04 | -0.07 | 0.02 |
EPS Growth | - | -87.86% | 255.42% | - | - | -85.12% |
Fiscal Year | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Daily Chemical Products Daily Chemical Products Growth | 932.78 | 928.85 | 866.77 |
Medicine Medicine Growth | 102.71 | 103.86 | 107.44 |
Unallocated Other Unallocated Other Growth | 14.37 | 12.5 | - |
Business Trade Business Trade Growth | 12.72 | 7.85 | 9.89 |
Total Total Growth | 1,063 | 1,053 | 984.09 |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 1,503 | 1,582 | 1,564 | 1,481 | 1,408 | 1,468 |
Total Debt Total Debt Growth | 102.68 | 106.13 | 96.67 | 84.86 | 44.31 | 77.13 |
Net Cash (Debt) Net Cash Growth | 1,401 | 1,476 | 1,467 | 1,396 | 1,364 | 1,391 |
Net Cash Growth | -6.58% | 0.63% | 5.08% | 2.35% | -1.92% | 65.29% |
Net Cash Per Share Net Cash Per Share Growth | 2.55 | 2.68 | 2.67 | 2.54 | 2.48 | 2.52 |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | -3.27 | 61.01 | 14.28 | 38.37 | 27.58 | -54.1 |
Capital Expenditures CapEx Growth | -63.6 | -48.26 | -29.77 | -26.55 | -22.11 | -26.2 |
Free Cash Flow Free Cash Flow Growth | -66.87 | 12.75 | -15.49 | 11.82 | 5.47 | -80.3 |
Free Cash Flow Growth | - | - | - | 116.16% | - | - |
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 15.46% | 16.26% | 16.27% | 16.16% | 15.68% | 19.94% |
Operating Margin | -7.31% | -4.12% | -4.65% | -3.83% | -8.89% | -3.56% |
Pretax Margin | -6.14% | 0.99% | 10.49% | 3.04% | -7.56% | 0.83% |
Profit Margin | -4.75% | 0.93% | 7.70% | 2.29% | -5.77% | 1.21% |
FCF Margin | -6.97% | 1.20% | -1.47% | 1.19% | 0.82% | -11.19% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 |
|---|---|---|---|---|
| Period Ending | Oct '26 Oct 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 |
Dividend Per Share Dividend Per Share Growth | 0.030 | 0.030 | 0.030 | 0.030 |
Dividend Per Share Growth | 0% | 0% | 0% | - |
Dividend Yield | 0.63% | 0.52% | 0.59% | 0.51% |
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 29, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | - | 321.19 | 34.52 | 140.84 | - | 346.20 |
Forward PE | - | 61.17 | 61.17 | 61.17 | 61.17 | 61.17 |
P/FCF Ratio | - | 247.94 | - | 271.82 | 528.20 | - |
PS Ratio | 2.75 | 2.98 | 2.66 | 3.23 | 4.32 | 4.18 |